SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001193125-11-036858
Filing Date
2011-02-15
Accepted
2011-02-15 17:16:37
Documents
1
Period of Report
2011-02-14
Filing Date Changed
2011-02-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 14641
  Complete submission text file 0001193125-11-036858.txt   16264
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27570 | Film No.: 11615128
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 1